Skip to main content
Erschienen in: CEN Case Reports 4/2019

08.06.2019 | Case Report

Uremic encephalopathy in patients undergoing assisted peritoneal dialysis: a case series and literature review

verfasst von: Akane Yanai, Kiyotaka Uchiyama, Yoshitaka Ishibashi

Erschienen in: CEN Case Reports | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

We sometimes hesitate to switch renal replacement therapy from peritoneal dialysis (PD) particularly in elderly patients due to their physical tolerance levels and lifestyles. Here, we describe the cases of three patients treated with PD alone despite an anuric status who subsequently developed uremic encephalopathy, which was successfully treated with hemodialysis (HD). The first patient was a 75-year-old woman who developed uremic encephalopathy with an anuric status and inadequate PD after 7 months of treatment. HD immediately improved her condition; encephalopathy did not recur with combined therapy of PD and HD. The second patient was a 69-year-old woman who developed anuria and was treated with combined therapy. Her arteriovenous fistula was obstructed; therefore, she was treated with PD alone. Total weekly Kt/V was sufficiently high at 1.95; however, she developed uremic encephalopathy the following month, which was successfully treated with HD. The third patient was an 84-year-old woman who developed anuria, but was treated with PD alone with adequate total weekly Kt/V of 2.2. PD could not be performed for 2 days because of myocardial infarction intervention; subsequently, she developed uremic encephalopathy, which was successfully treated with HD. These cases are the first of their kinds, wherein patients undergoing PD, developed uremic encephalopathy without any obvious triggers, including drugs, and illustrate the necessity of initiating combined therapy for such patients considering the risk of developing severe uremia leading to uremic encephalopathy, in spite of it being less preferable for elderly patients due to their physical conditions and lifestyles.
Literatur
1.
Zurück zum Zitat Suzuki H, Hoshi H, Inoue T, Kikuta T, Takane H, Takenaka T, Watanabe Y, Okada H, Kimura Y. Long-term survival benefits of combined hemodialysis and peritoneal dialysis. Adv Perit Dial. 2014;30:31–5.PubMed Suzuki H, Hoshi H, Inoue T, Kikuta T, Takane H, Takenaka T, Watanabe Y, Okada H, Kimura Y. Long-term survival benefits of combined hemodialysis and peritoneal dialysis. Adv Perit Dial. 2014;30:31–5.PubMed
2.
Zurück zum Zitat Kumar VA, Sidell MA, Jones JP, Vonesh EF. Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system. Kidney Int. 2014;86:1016–22.CrossRef Kumar VA, Sidell MA, Jones JP, Vonesh EF. Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system. Kidney Int. 2014;86:1016–22.CrossRef
3.
Zurück zum Zitat Denker BM, Chertow GM, Owen WF Jr. Hemodialysis. In: Brenner BM, editor. The kidney. 6th ed. Philadelphia: Saunders; 2000. p. 2373. Denker BM, Chertow GM, Owen WF Jr. Hemodialysis. In: Brenner BM, editor. The kidney. 6th ed. Philadelphia: Saunders; 2000. p. 2373.
4.
Zurück zum Zitat Lorber D. Nonketotic hypertonicity in diabetes mellitus. Med Clin North Am. 1995;79:39–52.CrossRef Lorber D. Nonketotic hypertonicity in diabetes mellitus. Med Clin North Am. 1995;79:39–52.CrossRef
5.
Zurück zum Zitat Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol. 2001;12:1927–36.PubMed Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol. 2001;12:1927–36.PubMed
6.
Zurück zum Zitat e Silva AD, Todorov JC, Lobo OD. Effect of experimentally induced chronic renal failure upon the behavior of rats. Nephron. 1979;24:78–80.CrossRef e Silva AD, Todorov JC, Lobo OD. Effect of experimentally induced chronic renal failure upon the behavior of rats. Nephron. 1979;24:78–80.CrossRef
7.
Zurück zum Zitat Ali BH, Ziada A, Al Husseni I, Beegam S, Nemmar A. Motor and behavioral changes in rats with adenine-induced chronic renal failure: influence of acacia gum treatment. Exp Biol Med. 2011;236:107–12 (Maywood).CrossRef Ali BH, Ziada A, Al Husseni I, Beegam S, Nemmar A. Motor and behavioral changes in rats with adenine-induced chronic renal failure: influence of acacia gum treatment. Exp Biol Med. 2011;236:107–12 (Maywood).CrossRef
8.
Zurück zum Zitat Tsuruya K. Brain atrophy and cognitive impairment in patients with chronic kidney disease. Nihon Rinsho. 2014;72:708–14 (in Japanese).PubMed Tsuruya K. Brain atrophy and cognitive impairment in patients with chronic kidney disease. Nihon Rinsho. 2014;72:708–14 (in Japanese).PubMed
9.
Zurück zum Zitat Jing W, Jabbari B, Vaziri ND. Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier. Am J Transl Res. 2018;10:2137–47.PubMedPubMedCentral Jing W, Jabbari B, Vaziri ND. Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier. Am J Transl Res. 2018;10:2137–47.PubMedPubMedCentral
10.
Zurück zum Zitat Adesso S, Paterniti I, Cuzzocrea S, Fujioka M, Autore G, Magnus T, Pinto A, Marzocco S. AST-120 reduces neuroinflammation induced by indoxyl sulfate in glial cells. J Clin Med. 2018;7:365.CrossRef Adesso S, Paterniti I, Cuzzocrea S, Fujioka M, Autore G, Magnus T, Pinto A, Marzocco S. AST-120 reduces neuroinflammation induced by indoxyl sulfate in glial cells. J Clin Med. 2018;7:365.CrossRef
11.
Zurück zum Zitat Malouf R, Brust JC. Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol. 1985;17:421–30.CrossRef Malouf R, Brust JC. Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol. 1985;17:421–30.CrossRef
12.
Zurück zum Zitat Votey SR, Peters AL, Hoffman JR. Disorders of water metabolism: hyponatremia and hypernatremia. Emerg Med Clin North Am. 1989;7:749–69.PubMed Votey SR, Peters AL, Hoffman JR. Disorders of water metabolism: hyponatremia and hypernatremia. Emerg Med Clin North Am. 1989;7:749–69.PubMed
13.
Zurück zum Zitat Gorban-Brennan N, Kliger AS, Finkelstein FO. CAPD therapy for patients over 80 years of age. Perit Dial Int. 1993;13:140–1.PubMed Gorban-Brennan N, Kliger AS, Finkelstein FO. CAPD therapy for patients over 80 years of age. Perit Dial Int. 1993;13:140–1.PubMed
14.
Zurück zum Zitat Taskapan H, Tam P, Leblanc D, Ting RH, Nagai GR, Chow SS, Fung J, Ng PS, Sikaneta T, Roscoe J, Oreopoulos DG. Peritoneal dialysis in the nursing home. Int Urol Nephrol. 2010;42:545–51.CrossRef Taskapan H, Tam P, Leblanc D, Ting RH, Nagai GR, Chow SS, Fung J, Ng PS, Sikaneta T, Roscoe J, Oreopoulos DG. Peritoneal dialysis in the nursing home. Int Urol Nephrol. 2010;42:545–51.CrossRef
15.
Zurück zum Zitat Chow KM, Wang AYM, Hui ACF, Wong TYH, Szeto CC, Li PKT. Nonconvulsive status epilepticus in peritoneal dialysis patients. Am J Kidney Dis. 2001;38:400–5.CrossRef Chow KM, Wang AYM, Hui ACF, Wong TYH, Szeto CC, Li PKT. Nonconvulsive status epilepticus in peritoneal dialysis patients. Am J Kidney Dis. 2001;38:400–5.CrossRef
16.
Zurück zum Zitat Hung SC, Hung SH, Tarng DC, Yang YC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2001;38:941–7.CrossRef Hung SC, Hung SH, Tarng DC, Yang YC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2001;38:941–7.CrossRef
17.
Zurück zum Zitat Chow KM, Szeto CC, Hui AC, Wong TY, Li PK. Retrospective review of neurotoxicity induced by cefepime and ceftazidime. Pharmacotherapy. 2003;23:369–73.CrossRef Chow KM, Szeto CC, Hui AC, Wong TY, Li PK. Retrospective review of neurotoxicity induced by cefepime and ceftazidime. Pharmacotherapy. 2003;23:369–73.CrossRef
18.
Zurück zum Zitat Tong MK, Siu YP, Yung CY, Kwan TH. Piperacillin/tazobactam-induced acute delirium in a peritoneal dialysis patient. Nephrol Dial Transplant. 2004;19:1341.CrossRef Tong MK, Siu YP, Yung CY, Kwan TH. Piperacillin/tazobactam-induced acute delirium in a peritoneal dialysis patient. Nephrol Dial Transplant. 2004;19:1341.CrossRef
19.
Zurück zum Zitat Lin CS, Cheng CJ, Chou CH, Lin SH. Piperacillin/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis. Am J Med Sci. 2007;333:181–4.CrossRef Lin CS, Cheng CJ, Chou CH, Lin SH. Piperacillin/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis. Am J Med Sci. 2007;333:181–4.CrossRef
20.
Zurück zum Zitat Ardalan MR, Pourafkari L, Tubbs RS, Shoja MM. Hypophosphatemic encephalopathy in a CAPD patient. Am J Med Sci. 2008;335:492–4.CrossRef Ardalan MR, Pourafkari L, Tubbs RS, Shoja MM. Hypophosphatemic encephalopathy in a CAPD patient. Am J Med Sci. 2008;335:492–4.CrossRef
21.
Zurück zum Zitat Kitamura M, Furusu A, Hirose M, Nishino T, Obata Y, Uramatsu T, Kohno S. A case of reversible posterior leukoencephalopathy syndrome in a patient on peritoneal dialysis. Clin Exp Nephrol. 2010;14:633–6.CrossRef Kitamura M, Furusu A, Hirose M, Nishino T, Obata Y, Uramatsu T, Kohno S. A case of reversible posterior leukoencephalopathy syndrome in a patient on peritoneal dialysis. Clin Exp Nephrol. 2010;14:633–6.CrossRef
22.
Zurück zum Zitat Lin CJ, Chen SP, Wang SJ, Fuh JL. Cefepime-related encephalopathy in peritoneal dialysis patients. J Chin Med Assoc. 2011;74:87–90.CrossRef Lin CJ, Chen SP, Wang SJ, Fuh JL. Cefepime-related encephalopathy in peritoneal dialysis patients. J Chin Med Assoc. 2011;74:87–90.CrossRef
23.
Zurück zum Zitat Ogawa A, Sugiyama H, Nakayama K, Morinaga H, Akagi S, Makino H. Reversible posterior leukoencephalopathy syndrome in a young adult patient receiving peritoneal dialysis. Perit Dial Int. 2012;32:587–9.CrossRef Ogawa A, Sugiyama H, Nakayama K, Morinaga H, Akagi S, Makino H. Reversible posterior leukoencephalopathy syndrome in a young adult patient receiving peritoneal dialysis. Perit Dial Int. 2012;32:587–9.CrossRef
24.
Zurück zum Zitat Lee J, Shin HS, Jung YS, Rim H. Two cases of baclofen-induced encephalopathy in hemodialysis and peritoneal dialysis patients. Ren Fail. 2013;35:860–2.CrossRef Lee J, Shin HS, Jung YS, Rim H. Two cases of baclofen-induced encephalopathy in hemodialysis and peritoneal dialysis patients. Ren Fail. 2013;35:860–2.CrossRef
25.
Zurück zum Zitat Safadi S, Mao M, Dillon JJ. Ceftriaxone-induced acute encephalopathy in a peritoneal dialysis patient. Case Rep Nephrol. 2014;2014:108185.PubMedPubMedCentral Safadi S, Mao M, Dillon JJ. Ceftriaxone-induced acute encephalopathy in a peritoneal dialysis patient. Case Rep Nephrol. 2014;2014:108185.PubMedPubMedCentral
26.
Zurück zum Zitat Graham BR, Pylypchuk GB. Posterior reversible encephalopathy syndrome in an adult patient undergoing peritoneal dialysis: a case report and literature review. BMC Nephrol. 2014;15:10.CrossRef Graham BR, Pylypchuk GB. Posterior reversible encephalopathy syndrome in an adult patient undergoing peritoneal dialysis: a case report and literature review. BMC Nephrol. 2014;15:10.CrossRef
27.
Zurück zum Zitat Chaitanya V, Sangeetha B, Reddy MH, Venkata Kumar AC, Ram R, Sivakumar V. Isoniazid cerebellitis in a peritoneal dialysis patient. Nephrology. 2016;21:442 (Carlton).CrossRef Chaitanya V, Sangeetha B, Reddy MH, Venkata Kumar AC, Ram R, Sivakumar V. Isoniazid cerebellitis in a peritoneal dialysis patient. Nephrology. 2016;21:442 (Carlton).CrossRef
28.
Zurück zum Zitat Kim CS, Bae EH, Ma SK, Kim SW. The case| seizure, ophthalmoplegia, and amnesia in a peritoneal dialysis patient. Kidney Int. 2016;90:1389–90.CrossRef Kim CS, Bae EH, Ma SK, Kim SW. The case| seizure, ophthalmoplegia, and amnesia in a peritoneal dialysis patient. Kidney Int. 2016;90:1389–90.CrossRef
29.
Zurück zum Zitat Nicotera R, Leonardi G, Castagna A, Cernaro V, Coppolino G. Wernicke–Korsakoff syndrome in end-stage renal disease: a case report. Ther Apher Dial. 2018;22:676–9.CrossRef Nicotera R, Leonardi G, Castagna A, Cernaro V, Coppolino G. Wernicke–Korsakoff syndrome in end-stage renal disease: a case report. Ther Apher Dial. 2018;22:676–9.CrossRef
Metadaten
Titel
Uremic encephalopathy in patients undergoing assisted peritoneal dialysis: a case series and literature review
verfasst von
Akane Yanai
Kiyotaka Uchiyama
Yoshitaka Ishibashi
Publikationsdatum
08.06.2019
Verlag
Springer Singapore
Erschienen in
CEN Case Reports / Ausgabe 4/2019
Elektronische ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-019-00406-3

Weitere Artikel der Ausgabe 4/2019

CEN Case Reports 4/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.